<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00998621</url>
  </required_header>
  <id_info>
    <org_study_id>ADH-HEPC-2009-01</org_study_id>
    <nct_id>NCT00998621</nct_id>
  </id_info>
  <brief_title>ADHEPTA Study: Adherence Questionnaire in Hepatitis C</brief_title>
  <acronym>ADHEPTA</acronym>
  <official_title>Development and Validation of a Questionnaire Measuring Treatment Adherence in Patients With Hepatitis C</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacion IMIM</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundacion IMIM</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Main objective: To study and validate a questionnaire measuring treatment adherence in
      patients with Hepatitis C virus (HCV) infection.

      Design of the study: Multicentric, prospective, epidemiological study in the field of usual
      clinical practice.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Main objective of the study is the development and validation of a Questionnaire measuring treatment adherence in patients with HCV infection.</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adherence will be measured according to 80/80/80 rule.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Establish a relationship between adherence, virological response (VR) and Sustained virological response (SVR).</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1120</enrollment>
  <condition>Hepatitis C, Chronic</condition>
  <condition>HIV Infection</condition>
  <arm_group>
    <arm_group_label>Hepatitis C infection</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Hepatitis C + HIV infections</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Adherence questionnaire</intervention_name>
    <description>Adherence questionnaire</description>
    <arm_group_label>Hepatitis C infection</arm_group_label>
    <arm_group_label>Hepatitis C + HIV infections</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with HCV and with HCV + HIV
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ambulatory patient infected by HCV according to diagnosis criteria used en usual
             clinical practice.

          -  Patient no treated previously and beginning a treatment for HCV.

          -  Patient that signed the informed consent to participate in the study.

          -  Group A: patient with HCV monoinfection.

          -  Group B: patient with HCV and HCV co-infection (according to diagnosis criteria used
             en usual clinical practice).

        Exclusion Criteria:

          -  Patient that received previous treatment for HCV.

          -  Patient that is going to participate in a clinical trial Turing the HCV treatment
             period.

          -  Patient with cognitive impairment or patient unable to understand and answer the
             auto-administered questionnaire.

          -  Patient unable to read or write Spanish.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 19, 2009</study_first_submitted>
  <study_first_submitted_qc>October 19, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2009</study_first_posted>
  <last_update_submitted>October 14, 2015</last_update_submitted>
  <last_update_submitted_qc>October 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hepatitis C, Chronic</keyword>
  <keyword>HIV Infection</keyword>
  <keyword>Medication Adherence</keyword>
  <keyword>Questionnaire Design</keyword>
  <keyword>Treatment experienced</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Hepatitis C, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

